X Square Capital, LLC Heron Therapeutics, Inc. Transaction History

X Square Capital, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$1.11 - $2.88 $129,511 - $336,029	-116,677 Reduced 78.91%	31,185 $36,000
Q4 2022 Feb 02, 2023	BUY	$2.25 - $4.67 $213,750 - $443,650	95,000 Added 179.71%	147,862 $370,000
Q2 2022 Aug 05, 2022	SELL	$2.3 - $6.29 $1,150 - $3,145	-500 Reduced 0.94%	52,862 $147,000
Q4 2021 Feb 14, 2022	BUY	$8.35 - $12.6 $835 - $1,260	100 Added 0.19%	53,362 $487,000
Q3 2021 Nov 12, 2021	SELL	$10.13 - $15.0 $40,509 - $59,985	-3,999 Reduced 6.98%	53,262 $569,000
Q2 2021 Aug 16, 2021	BUY	$13.27 - $18.48 $550,200 - $766,217	41,462 Added 262.43%	57,261 $889,000
Q1 2021 May 13, 2021	BUY	$14.49 - $20.72 $63,741 - $91,147	4,399 Added 38.59%	15,799 $256,000
Q4 2020 Feb 12, 2021	BUY	$14.61 - $22.14 $20,454 - $30,996	1,400 Added 14.0%	11,400 $241,000
Q1 2020 May 19, 2020	BUY	$10.23 - $24.56 $102,300 - $245,600	10,000 New	10,000 $117,000

180

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $133M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of X Square Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on X Square Capital, LLC with notifications on news.